제19613호                                       관                 보                      2019. 10. 25.(금요일)
연번           물질명                                                 화학명칭                                   1/2군 효력기간
 86 5-MeO-2-TMT                   2-(5-methoxy-2-methyl-H-indol-3-yl)-N,N-dimethylethanamine              2
                                  5-chloro-3-ethyl-N-[4-(piperidine-1-yl)phenethyl]-1H-indole-2-carb
 87    Org27569                                                                                           2
                                  oxamide
 88    Mephtetramine              3,4-dihydro-2-[(methylamino)methyl]-1(2H)-naphthalenone                 2
                                  7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodi
 89    Diclazepam                                                                                         2
                                  azepin-2-one
 90    5-MAPDB                    1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine                   2
 91    2C-B-FLY                   2-(4-bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-8-yl)ethanamine   2
 92    Methoxmetamine             2-(3-methoxyphenyl)-2-(methylamino)cyclohexanone                        2
 93    3-MeO-PCMo                 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine                             2
                                  1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridi
 94    CUMYL-5F-P7AICA                                                                                    2
                                  ne-3-carboxamide
       4-Fluorobutyrfentanyl      N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanam
 95                                                                                                       1
       (4-FBF)                    ide
       Methylnaphtidate
 96                               methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl) acetate                   2
       (HDMP-28)
 97    Isopropylphenidate         propan-2-yl2-phenyl-2-(piperidin-2-yl) acetate                          2
       3-Fluorophenmetrazine
 98                               2-(3-fluorophenyl)-3-methylmorpholine                                   2
       (3-FPM)
  99   Mephenmetrazine            2-(4-methylphenyl)-3-methylmorpholine                                   2
 100   DF-MDBP                    1-[(2,2-difluorobenzo[d][1,3]dioxol-5-yl)methyl]piperazine              2
                                  methyl (E)-2-[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,
 101   7-Hydroxymitragynine       3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxypr      1
                                  op-2-enoate
                                  methyl (E)-2-[(2S,3S)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydro-
 102   Mitragynine                1H-indolo[3,2-h] quinolizin-2-yl]-3-methoxyprop-2-enoic acid methyl     1
                                  ester
 103   2-Fluorofentanyl           N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide       1
                                                                                                              ’19.7.31~
 104   p-Methoxybutyrfentanyl     N-(4-methoxyphenyl)-N-[1[(2-phenylethyl)piperidin-4-yl]butanamide       1
                                                                                                                 ’22.7.30.
 105   3-HO-PCP                   3-(1-piperidin-1-ylcyclohexyl)phenol                                    2
                                  8-bromo-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]be
 106   Flubromazolam                                                                                      2
                                  nzodiazepine                                                                ’19.9.10~
                                  1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-pyrrolo[2,3-b]p                 ’22.9.9.
 107   Cumyl-4CN-B7AICA                                                                                   2
                                  yridine-3-carboxamide



◉금융위원회공고제2019-405호
｢상호저축은행법 시행령｣을 일부 개정함에 있어, 그 개정이유와 주요내용을 국민에게 미리 알려 이
에 대한 의견을 듣기 위하여 ｢행정절차법｣
제 41조에 따라 다음과 같이 「상호저축은행법 시행령」을 공고합니다.
       2019년 10월 25일
                          금융위원회 위원장
                               상호저축은행법 시행령 일부개정령(안) 입법예고
1. 개정이유
 상호저축은행법이 개정(‘18.12.31.)되어 약관 제․개정시 원칙적 사전신고제가 사후보고제로 전환됨
 에 따라, 시행령에 위임한 예외적 사전신고대상을 규정하기 위함
2. 주요내용
 가. 약관 제‧개정시 사전신고 대상을 규정(안 제11조의3)
      기존 이용자에게 적용되는지 여부, 기존 금융서비스와 차별화된 내용이 포함되는지 여부 등을 감
      안하여 약관 사전신고 대상을 규정

                                                        114